1998 News
Dec 16, 1998Abgenix and Research Corporation Technologies To Collaborate on Human Antibody for Immune Tolerance
Nov 20, 1998New Anticonvulsant Agent, Harkoseride, Entering Phase II Clinical Program
Jun 02, 1998Technology for Sertoli Cell-based Therapies Awarded Second U.S. Patent
Mar 12, 1998Phase I Clinical Trials Prove Fluasterone's Safety, Low Androgenicity
Mar 10, 1998U.S. Patent Awarded for Novel Use of Sertoli Cells in Transplant Therapies
Feb 10, 1998RCT and Royal Bank are Partners in Life Science Venture Firm, Milestone Medica
Feb 05, 1998